CSIMarket Company Name, Ticker, Competitors, else..
 
Fresh Tracks Therapeutics Inc   (FRTX)
 
Price: $0.9350 $0.00 -0.532%
Day's High: $0.94 Week Perf: 2.75 %
Day's Low: $ 0.94 30 Day Perf: 35.51 %
Volume (M): 2,400 52 Wk High: $ 0.00
Volume (M$): $ 2 52 Wk Avg: $0.00
Open: $0.94 52 Wk Low: $0.00



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 5
 Employees 28
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 0

Business Description


Fresh Tracks Therapeutics Inc is a biotechnology company that focuses on the development of innovative therapies for various medical conditions. They are committed to discovering and advancing novel treatments that can improve the lives of patients. The company utilizes cutting-edge research and technology to identify potential drug candidates and conducts rigorous clinical trials to determine their safety and efficacy. Fresh Tracks Therapeutics Inc aims to address unmet medical needs and bring new treatments to market that have the potential to make a significant impact in healthcare.


   Company Address: 2000 Central Avenue, Boulder, 80301 CO
   Company Phone Number: 505-4755   Stock Exchange / Ticker: FRTX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ADAP        12.96% 
AMGN        1.11% 
ARGX        0.97% 
BIIB        1.07% 
IMA   -9.18%    
ITOS   -0.39%    
• View Complete Report
   



Shares

Fresh Tracks Therapeutics Moves Listing to OTC Pink Market

Published Tue, Dec 19 2023 10:19 PM UTC


BOULDER, Colo., Dec. 19, 2023 - Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX), a leading biotechnology company, has announced that its common stock has been suspended from trading on The Nasdaq Capital Market. The company s stock will now be quoted on the OTC Pink market under the same trading symbol, FRTX. Fresh Tracks has also withdrawn its appeal of Nasdaq s decis...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.63
Price to Sales (Expected) -
Price to Book 0.51
PEG (TTM) -

Financial Strength Current
Quick Ratio 6.56
Working Capital Ratio 6.98
Leverage Ratio (MRQ) 0.17
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.4 $
Revenues (TTM) 1.48 $
Cash Flow (TTM) 0.41 $
Cash 2.01 $
Book Value 1.84 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -203,357
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.